Precisely how these putative mechanisms lead to loss of nuclear TAR DNA-binding protein 43 (TDP-43) and TDP-43 aggregation that is characteristic of C9orf72-associated ALS/FTD (C9-ALS/FTD) neuropathology remains unknown. This evidence concerns the gene TARDBP and frontotemporal dementia.